Akebia Therapeutics
AKBA
AKBA
87 hedge funds and large institutions have $73.5M invested in Akebia Therapeutics in 2023 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 23 increasing their positions, 20 reducing their positions, and 4 closing their positions.
Holders
87
Holders Change
+11
Holders Change %
+14.47%
% of All Funds
1.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
15
Increased
23
Reduced
20
Closed
4
Calls
$1.33M
Puts
$494K
Net Calls
+$835K
Net Calls Change
-$500K
Top Buyers
1 |
1
Goldman Sachs
New York
|
$4.83M |
2 |
2
Renaissance Technologies
New York
|
$5.93M |
3 |
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$2.68M |
4 |
4
Morgan Stanley
New York
|
$1.67M |
5 |
5
BlackRock
New York
|
$3.87M |